This Solicitation opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BUTORPHANOL TARTRAT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Butorphanol Tartrate Injection, Veterinary, 10 mg/mL in 50 mL vials, is being procured by the Department of Defense for pain relief associated with colic in adult horses and yearlings. The drug is classified as a DEA Schedule IV controlled substance and must be stored at controlled room temperature between 20–25°C (68–77°F) in a secured location. Each vial is the unit of issue, with a total quantity of 19 vials required under solicitation SPE2DP-26-T-3328, to be delivered within 89 days to APO AE 09227-0000 under FOB Destination terms. The item has a non-extendable shelf life of 24 months and is subject to specific labeling and packaging requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and packaging must conform to MIL-STD-2073-1E. The product is regulated by the FDA, and the contracting official must refer to the product specialist for confirmation prior to award. The solicitation requires compliance with a full suite of Federal Acquisition Regulation clauses, including cybersecurity safeguards under FAR 252.204-7012, preservation of government information under 252.204-7000, and whistleblower rights notification under 252.203-7002. Contractors must ensure all hazardous materials are labeled according to 29 CFR 1910.1200 and disclose applicable exemptions. The shipment must comply with the requirement for U.S.-flag vessels unless a waiver is granted, and all invoicing must occur via Wide Area WorkFlow. The item is sourced from multiple manufacturers, including Zoetis Inc., Covetrus North America, Patterson Veterinary Supply, Merck Sharp & Dohme, and MWI Veterinary Supply, each with specified part numbers and NDCs. Offerors must provide a Unique Entity ID and CAGE code, declare small business status if applicable, and certify compliance with socioeconomic programs. All submissions are required through the DLA Internet Bid Board System by the deadline of May 18, 2026, and acceptance occurs at the destination following inspection per FAR 52.246-2.
General Info
Agency
Contract Value
$3,363NAICS
Place of Performance
ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USASet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
BUTORPHANOL TARTRATE INJECTION, VETERINARY
.
10 MG/ML, 50 ML VIAL; FOR PAIN RELIEF ASSOCIATED WITH
COLIC IN ADULT HORSES AND YEARLINGS;
DEA SCHEDULED DRUG CLASS IV
.
UNIT OF ISSUE: VIAL (VI) OF 50ML.
.
STORE AT CONTROLLED ROOM TEMPERATURE 20-25C (68-77F); SECURED (C-IV)
.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
ZOETIS INC. 0M1P3 P/N 10009984 ZOETIS INC. 0M1P3 P/N NDC54771-2033-20 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 029088 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-803-7090 MERCK SHARP & DOHME LLC 6B2S4 P/N 017070 MWI VETERINARY SUPPLY, INC. 1VLG2 P/N NDC67185-0722-66
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3328
SECTION B
PR: 7016722190 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016722190 0001 VI 19.000
NSN/MATERIAL:6509015310967
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-531-0967 Quantity: 19 VI Purchase Request: 7016722190QTY: 19 Delivery: 89 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS